Attorneys for Luigi Mangione have held discussions with prosecutors regarding the potential for a plea agreement in his federal case, which stems from the December 2024 killing of UnitedHealthcare’s chief executive. This information was provided by a source familiar with the proceedings who spoke on the condition of anonymity due to the active nature of the case.
The source noted that while such conversations are common in major federal litigation, they did not lead to a finalized agreement between the parties. Mangione is scheduled for a federal court appearance on Monday, where participants are expected to address jury selection and juror questionnaires, though it is considered unlikely that plea negotiations will be revisited at that time.
The 28-year-old defendant, currently facing charges in both federal and state court systems, has entered a plea of not guilty to all counts. Within the federal indictment, he faces two charges of stalking; prosecutors contend that he stalked UnitedHealthcare CEO Brian Thompson online before traveling across state lines to execute the killing. These specific charges carry a maximum penalty of life imprisonment without the possibility of parole.
Neither the US Attorney’s Office for the Southern District of New York nor Mangione’s defense counsel offered immediate comments on the matter. The federal trial is anticipated to take place following the conclusion of proceedings in New York state, where Mangione is scheduled to stand trial for murder and weapons charges starting September 8. A conviction in the state case could also result in a sentence of up to life in prison.
Both legal cases are centered on the death of Thompson, who was shot and killed on the morning of December 4, 2024, while walking to a Midtown Manhattan hotel for an annual investors’ conference held by his firm. Five days following the shooting, Mangione, an Ivy League graduate, was apprehended at a McDonald’s establishment located in Altoona, Pennsylvania.
Mangione and his legal team have consistently voiced opposition to the dual nature of these state and federal prosecutions, citing difficulties in managing preparations for two simultaneous trials. Earlier this year, a US judge dismissed the murder charge from the federal indictment, which eliminated the possibility for Southern District of New York prosecutors to pursue the death penalty in that trial.
